...
首页> 外文期刊>International Journal of Pharmaceutics >Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential
【24h】

Methotrexate loaded lipid nanoparticles for topical management of skin-related diseases: Design, characterization and skin permeation potential

机译:甲氨蝶呤负载脂质纳米粒用于皮肤相关疾病的局部治疗:设计,表征和皮肤渗透潜力

获取原文
获取原文并翻译 | 示例
           

摘要

Methotrexate exhibits poor cutaneous bioavailability when administered topically using conventional vehicles. It is recommended for the treatment of skin-related diseases but its systemic side effects hamper application. The aim of this work was to formulate methotrexate in nanostructured lipid carriers using biocompatible lipids, and to investigate their potential for topical drug delivery. Methotrexateloaded nanostructured lipid carriers were prepared via a hot ultrasonication method. Nanocarriers were evaluated for size, polydispersity, surface potential and entrapment efficiency. Shape and surface morphology of the produced lipid carriers confirmed their spherical shape. After 10 h ca. 50% of methotrexate was released in vitro from the lipid nanocarriers following Peppas-Korsmeyer release kinetics. Moreover, methotrexate-loaded nanocarriers were stable at least for 3 months and less toxic towards fibroblasts and human keratinocytes than the free drug. Methotrexate within lipid nanocarriers was able to pass the experimental keratinocyte epidermal barrier at a flux rate of 2 mu g cm(-2) h(-1). Results demonstrated that lipid nanocarriers constitute a suitable approach for application of methotrexate in skin-related diseases topical therapy. (C) 2016 Elsevier B.V. All rights reserved.
机译:当使用常规载体局部给药时,甲氨蝶呤表现出较差的皮肤生物利用度。建议用于治疗与皮肤有关的疾病,但其全身性副作用妨碍了其应用。这项工作的目的是使用生物相容性脂质在纳米结构脂质载体中配制甲氨蝶呤,并研究其在局部药物递送中的潜力。通过热超声法制备载有甲氨蝶呤的纳米结构脂质载体。评价纳米载体的尺寸,多分散性,表面电势和包封效率。产生的脂质载体的形状和表面形态证实了它们的球形。约10小时后。遵循Peppas-Korsmeyer释放动力学,从脂质纳米载体中体外释放了50%的甲氨蝶呤。此外,负载甲氨蝶呤的纳米载体至少可以稳定3个月,并且对成纤维细胞和人角质形成细胞的毒性比游离药物低。脂质纳米载体中的甲氨蝶呤能够以2μg cm(-2)h(-1)的通量速率通过实验性角质形成细胞表皮屏障。结果表明脂质纳米载体构成了甲氨蝶呤在皮肤相关疾病局部治疗中应用的合适方法。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号